UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 410

Sortiert nach

Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update

International journal of molecular sciences, 2019-12, Vol.20 (24), p.6141

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges

Journal of hematology and oncology, 2019-04, Vol.12 (1), p.39-39, Article 39

2019

Link zum Volltext

Verfügbarkeit prüfen

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

Molecular cancer, 2018-02, Vol.17 (1), p.49-49, Article 49

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?

International journal of molecular sciences, 2021-07, Vol.22 (13), p.7093

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?

Journal of clinical medicine, 2020-11, Vol.9 (12), p.3865

2020

Link zum Volltext

Verfügbarkeit prüfen

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies

Journal of experimental & clinical cancer research, 2022-04, Vol.41 (1), p.159-159, Article 159

2022

Link zum Volltext

Verfügbarkeit prüfen

Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia

Leukemia, 2022-05, Vol.36 (5), p.1227-1236

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities

International journal of molecular sciences, 2021-07, Vol.22 (13), p.6857

2021

Link zum Volltext

Verfügbarkeit prüfen

Resistance mutations in CML and how we approach them

Hematology, 2023-12, Vol.2023 (1), p.469

Soverini, Simona

2023

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy

International journal of molecular sciences, 2020-06, Vol.21 (11), p.3987

2020

Link zum Volltext

Verfügbarkeit prüfen

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper

Journal of hematology and oncology, 2019-12, Vol.12 (1), p.131-131, Article 131

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4204-4210

2009

Link zum Volltext

Verfügbarkeit prüfen

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia

Leukemia research, 2014-01, Vol.38 (1), p.10-20

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2015-06, Vol.15, p.S120-S128

2015

Link zum Volltext

Verfügbarkeit prüfen

IKZF1 (Ikaros) Deletions in BCR-ABL1–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5202-5207

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network

Journal of cancer research and clinical oncology, 2021-10, Vol.147 (10), p.3081-3089

2021

Link zum Volltext

Verfügbarkeit prüfen

EXABS-114-CML Non BCR::ABL1 Mutations in CML: Do They Matter?

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22 Suppl 2, p.S15-S17

Soverini, Simona

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 410

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(397)
Mit Volltextzugriff
(400)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(150)
Humans
(131)
Hematology
(99)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(66)
Male
(65)
Oncology
(65)
Female
(64)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(63)
Adult
(61)
Middle Aged
(59)
Fusion Proteins, Bcr-Abl - Genetics
(56)
Protein Kinase Inhibitors - Therapeutic Use
(54)
Aged
(53)
Chronic Myeloid Leukemia
(52)
Biological And Medical Sciences
(46)
Medical Sciences
(44)
Imatinib Mesylate
(43)
Leukemia
(42)
Mutation
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(192)
Cancer Research
(31)
Haematologica
(24)
Clinical Lymphoma, Myeloma And Leukemia
(21)
Journal Of Clinical Oncology
(14)
Leukemia
(9)
American Journal Of Hematology
(7)
Leukemia Research
(7)
Plos One
(7)
Clinical Cancer Research
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?

Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies

Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia

The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities

Resistance mutations in CML and how we approach them

Chromothripsis in acute myeloid leukemia: biological features and impact on survival

Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy

Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper

BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia

Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia

IKZF1 (Ikaros) Deletions in BCR-ABL1–Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

Contribution of ABL Kinase Domain Mutations to Imatinib Resistance in Different Subsets of Philadelphia-Positive Patients: By the GIMEMA Working Party on Chronic Myeloid Leukemia

BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS

Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia

Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network

ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis and Shorter Survival: A Study by the GIMEMA Working Party on Chronic Myeloid Leukemia

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1–positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP)

EXABS-114-CML Non BCR::ABL1 Mutations in CML: Do They Matter?

Suchergebnisse filtern